Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood

European Journal of Pediatric Surgery

Volumn 11, Issue 3, 2001, Pages 207-210

  Agarwala, S ^a   Hemal, A K ^a   Seth, A ^a   Gupta, A K ^a   Bhatnagar, V ^a   Mitra, D K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cyclophosphamide; Second malignancy; Transitional cell carcinoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD; DRUG EXPOSURE; EMBRYONAL RHABDOMYOSARCOMA; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; SECOND CANCER; TRANSITIONAL CELL CARCINOMA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYSTOSCOPY; DACTINOMYCIN; FOLLOW-UP STUDIES; HUMANS; MALE; MONITORING, PHYSIOLOGIC; RADIOTHERAPY, ADJUVANT; RHABDOMYOSARCOMA; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINCRISTINE;

EID: 0034952685     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15486     Document Type: Article

References (32)

1. Cyclophosphamide-induced non-hemorrhagic cystitis with abnormal bladder cells
2. Transitional cell carcinoma of the bladder in children and adolescents
3. Cyclophosphamide cystitis and bladder cancer: A hypothesis
4. Bladder cancer following administration of cyclophosphamide
5. Acute leukemia after chemotherapy (melphalan)
6. Second malignant tumours following treatment during childhood and adolescence for cancer
7. The growth inhibitory and carcinogenic properties of 4-aminostilbene and derivatives
8. Acute leukemia following cyclophosphamide therapy for Sjogren's syndrome
9. Transitional cell carcinoma of the bladder in the pediatric patients
10. Primary epithelial tumours of the bladder in the first two decades of life
11. Bladder tumors following chemotherapy and radiotherapy for ovarian cancer: A case-control study
12. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
13. Urological complications of cyclophosphamide
14. Second malignant neoplasms in children: An update from the late effect study group
15. Late effects of treatment of children with cancer
16. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma
17. Incidence, previous treatment and chromosome characteristics of secondary acute non-lymphocytic leukemia
18. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis
19. Second malignant neoplasms in children after treatment of soft tissue sarcoma
20. Second tumours after treatment of childhood malignancies
21. Hodgkin's disease and acute leukemia. A report of 8 cases and review of literature
22. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of literature
23. Cancer of the bladder
24. Occurrence of second tumours in man after anticancer treatment
25. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna
26. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents
27. Cyclophosphamide-induced hemorrhagic cystitis - A review of 100 patients
28. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis
29. Bladder and kidney cancer following cyclophosphamide therapy for NHL
30. Cancer risk following treatment of childhood cancer
31. Carcinoma of the urinary bladder in patients receiving cyclophosphamide
32. Cyclophosphamide and the bladder